Franklin Biotechnology Discovery Fund Investor Sentiment

FRBRX Fund  USD 131.21  2.39  1.79%   
Slightly above 61% of Franklin Biotechnology's investor base is looking to short. The analysis of overall sentiment of trading Franklin Biotechnology Discovery mutual fund suggests that many investors are alarmed at this time. Franklin Biotechnology's investing sentiment can be driven by a variety of factors including economic data, Franklin Biotechnology's earnings reports, geopolitical events, and overall market trends.
  
over three months ago at news.google.com         
Franklin Biotechnology Discovery Fund Q3 2024 Commentary - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Franklin Biotechnology Discovery Fund Q2 2024 Commentary - Seeking Alpha
Google News at Macroaxis
a day ago at thelincolnianonline.com         
Growth Stocks To Follow Now March 24th
news
few days ago at gurufocus.com         
Incyte Stock Declines Due to Clinical Trial Results
Gurufocus Stories at Macroaxis
few days ago at thelincolnianonline.com         
Incyte Co. Shares Acquired by DCF Advisers LLC
news
few days ago at finance.yahoo.com         
DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance DelveInsigh...
Yahoo News
six days ago at finance.yahoo.com         
HUTCHMED and Innovent Jointly Announce that the FRUSICA-2 PhaseIIIII Study of Fruquintinib and Sinti...
Yahoo News
over a week ago at businesswire.com         
Resumen Incyte anunci resultados positivos de datos principales en dos ensayos clnicos de fase 3 sob...
businesswire News
over a week ago at finance.yahoo.com         
Coinbase initiated, Block upgraded Wall Streets top analyst calls
Yahoo News
over a week ago at cnbc.com         
Stocks making the biggest moves midday Intel, Tesla, Affirm, Robinhood and more
cnbc News
over a week ago at businesswire.com         
Incyte gibt positive Topline-Ergebnisse aus zwei klinischen Phase-3-Studien mit Povorcitinib bei Pat...
businesswire News
over a week ago at finance.yahoo.com         
Incytes New Treatment for Chronic Skin Disease Shows Promising Results In Latest Clinical Trials, St...
Yahoo News
a day ago at finance.yahoo.com         
Is Array Technologies Inc. the Best Solar Stock to Buy in 2025?
Yahoo News
few days ago at news.google.com         
Array Technologies Faces Pricing Challenges and Revenue Adjustments Amid International ASP Declines ...
Google News at Macroaxis
over a week ago at www.macroaxis.com         
Acquisition by Terrance Collins of 51386 shares of Array Technologies subject to Rule 16b-3
Macroaxis News
over a week ago at gurufocus.com         
ARRAY Technologies, Inc. to Participate in the 37th Annual ROTH Conference
Gurufocus Stories at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 2206 shares by Neil Manning of Array Technologies at 6.03 subject to Rule 16b-3
Macroaxis News
over three weeks ago at finance.yahoo.com         
Array Technologies Full Year 2024 Earnings EPS Misses Expectations
Yahoo News
over three weeks ago at gurufocus.com         
Array Technologies Inc Q4 2024 Earnings Call Highlights Strong Margins and Strategic ...
Gurufocus Stories at Macroaxis
over three weeks ago at finance.yahoo.com         
Why Array Shares Are Trading Lower Today
Yahoo News
over three weeks ago at gurufocus.com         
ARRAY Technologies, Inc. Reports Financial Results for the Fourth Quarter and Full Year 2024
Gurufocus Stories at Macroaxis
over three weeks ago at benzinga.com         
Array Technologies Stock Drops After Mixed Q4 Results, Weak Forward Guidance
benzinga news
a minute ago at finance.yahoo.com         
Heres What Key Metrics Tell Us About Vertex Q4 Earnings
Yahoo News
2 days ago at seekingalpha.com         
Vertex Resource Group Ltd. reports Q4 results
seekingalpha News
3 days ago at thelincolnianonline.com         
Simplify Asset Management Inc. Acquires Shares of 4,689 Vertex Pharmaceuticals Incorporated
news
few days ago at finance.yahoo.com         
Acquisition by Altshuler David of 7114 shares of Vertex Pharmaceuticals subject to Rule 16b-3
Yahoo News
few days ago at benzinga.com         
100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
benzinga news
few days ago at finance.yahoo.com         
Crunchbase Hires Ann Davis as Senior Vice President of Sales to Scale AI-Powered Market Intelligence
Yahoo News
few days ago at finance.yahoo.com         
The Zacks Analyst Blog Highlights Alphabet, Amazon, Microsoft and Oracle
Yahoo News
six days ago at zacks.com         
Vertex Pharmaceuticals Rises But Trails Market What Investors Should Know
zacks News
six days ago at insidermonkey.com         
Is Vertex Pharmaceuticals the Best Diabetes Stock to Buy According to Billionaires?
insidermonkey News
over a week ago at finance.yahoo.com         
NVIDIA, Alphabet and Google Collaborate on the Future of Agentic and Physical AI
Yahoo News
over a year ago at reuters.com         
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
reuters
over a year ago at seekingalpha.com         
Pfizer stock slips as 2024 guidance disappoints
seekingalpha News
over a year ago at cnbc.com         
Why investors should only trade a name like Linde on fundamentals
cnbc News
over a year ago at finance.yahoo.com         
Were Interested To See How Seagen Uses Its Cash Hoard To Grow
Yahoo News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at dragonflycap.com         
5 Trade Ideas for MondayArista, Comerica, Interactive Brokers, Seagen and Teck Resources
news
over a year ago at benzinga.com         
100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
benzinga news
over a year ago at businesswire.com         
TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Fr...
businesswire News
over a year ago at thelincolnianonline.com         
Seagen Inc. Receives 193.00 Average PT from Analysts
news
over a year ago at www.macroaxis.com         
Disposition of 49701 shares by Michael Wortley of Reata Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Reata Pharmaceuticals, Inc. Is Expected To Breakeven In The Near Future - Yahoo Finance
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Reata Pharmaceuticals Research Coverage Started at StockNews.com
news
over a year ago at thelincolnianonline.com         
Reata Pharmaceuticals, Inc. Given Consensus Rating of Hold by Analysts
news
over a year ago at thelincolnianonline.com         
StockNews.com Begins Coverage on Reata Pharmaceuticals
news
over a year ago at www.macroaxis.com         
Sale by Michael Wortley of 807 shares of Reata Pharmaceuticals
Macroaxis News
over a year ago at zacks.com         
Alimera Sciences Reports Q2 Loss, Lags Revenue Estimates
zacks News
over a year ago at zacks.com         
Entrada Therapeutics, Inc. Reports Q2 Loss, Misses Revenue Estimates
zacks News
over a year ago at benzinga.com         
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates RETA, EQRX, DFFN
benzinga news
over a year ago at Macroaxis         
Ready to invest in Reata Pharmaceuticals now and drop it in two-three weeks?
Macroaxis News
a minute ago at zacks.com         
Regeneron Q4 Earnings and Revenues Beat Estimates
zacks News
2 days ago at thelincolnianonline.com         
Crowley Wealth Management Inc. Acquires Shares of 50 Regeneron Pharmaceuticals, Inc.
news
few days ago at thelincolnianonline.com         
Regeneron Pharmaceuticals, Inc. Shares Purchased by Umpqua Bank
news
few days ago at thelincolnianonline.com         
Advisors Asset Management Inc. Sells 443 Shares of Regeneron Pharmaceuticals, Inc.
news
few days ago at thelincolnianonline.com         
Avantax Advisory Services Inc. Purchases 404 Shares of Regeneron Pharmaceuticals, Inc.
news
few days ago at finance.yahoo.com         
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update...
Yahoo News
over a week ago at finance.yahoo.com         
Regeneron Pharmaceuticals Among the Best Biotech Stocks to Buy According to Billionaires
Yahoo News
over a week ago at finance.yahoo.com         
Amgen Rises Almost 22 percent YTD Should You Buy, Hold or Sell the Stock?
Yahoo News
over a week ago at thelincolnianonline.com         
Best Medical Stocks To Keep An Eye On March 14th
news
over a week ago at thelincolnianonline.com         
Regeneron Pharmaceuticals, Inc. Shares Sold by Copperwynd Financial LLC
news
a day ago at news.google.com         
Cibc World Markets Corp Invests 322,000 in PTC Therapeutics, Inc. - MarketBeat
Google News at Macroaxis
few days ago at gurufocus.com         
Insider Sell Alert Eric Pauwels Sells Shares of PTC Therapeutics Inc
Gurufocus Stories at Macroaxis
six days ago at thelincolnianonline.com         
PTC Therapeutics, Inc. Receives Average Recommendation of Moderate Buy from Brokerages
news
over a week ago at news.google.com         
PTC Therapeutics Reports Q4 Earnings What Key Metrics Have to Say - MSN
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Disposition of 5000 shares by Okey Stephanie of PTC Therapeutics at 54.0 subject to Rule 16b-3
Yahoo News
over two weeks ago at seekingalpha.com         
Disposition of 1719 shares by Mark Boulding of PTC Therapeutics at 33.02 subject to Rule 16b-3
seekingalpha News
over two weeks ago at thelincolnianonline.com         
Inceptionr LLC Cuts Stake in PTC Therapeutics, Inc.
news
over two weeks ago at gurufocus.com         
Insider Sell Allan Jacobson Sells Shares of PTC Therapeutics Inc
Gurufocus Stories at Macroaxis
over three weeks ago at finance.yahoo.com         
Novartis Gets CHMP Opinion for Label Expansion of Fabhalta
Yahoo News
over three weeks ago at simplywall.st         
PTC Therapeutics Full Year 2024 Earnings Misses Expectations
Simply Wall St News at Macroaxis
a day ago at finance.yahoo.com         
The industry heavyweight behind Novavaxs push to bounce back
Yahoo News
over a week ago at finance.yahoo.com         
Factbox-Widely used drugs on US imports list from Europe
Yahoo News
over a week ago at fool.com         
2 Beaten-Down Stocks Near Their 52-Week Lows That Arent Worth Buying
fool News
over two weeks ago at finance.yahoo.com         
Need To Know Analysts Just Made A Substantial Cut To Their Novavax, Inc. Estimates
Yahoo News
over two weeks ago at investors.com         
Disposition of 12223 shares by Kelly James Patrick of Novavax subject to Rule 16b-3
Investors Business Daily at Macroaxis
over two weeks ago at newsweek.com         
Gene-based vaccines could be banned in Iowa under new bill
news
over two weeks ago at desmoinesregister.com         
Iowa bill asks vaccine manufacturers to waive indemnity against injury lawsuits
news
over three weeks ago at finance.yahoo.com         
Disposition of 19600 shares by Ohara Elaine of Novavax subject to Rule 16b-3
Yahoo News
over three weeks ago at insidermonkey.com         
Novavax, Inc. Q4 2024 Earnings Call Transcript
insidermonkey News
over three weeks ago at gurufocus.com         
Novavax Inc Q4 2024 Earnings Call Highlights Strategic Partnerships and Financial ...
Gurufocus Stories at Macroaxis
over a year ago at thelincolnianonline.com         
Mirati Therapeutics Now Covered by Analysts at StockNews.com
news
over a year ago at finance.yahoo.com         
Billionaire Joe Lewis Pleads Guilty in Insider Trading Case
Yahoo News
over a year ago at smh.com.au         
Billionaire pleads guilty in insider trading case with a link to an Australian giant
news
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at aol.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
news
over a year ago at seekingalpha.com         
Mirati Therapeutics stock ticks higher amid Nasdaq delisting for sale to Bristol-Myers
seekingalpha News
over a year ago at thelincolnianonline.com         
Brokerages Set Mirati Therapeutics, Inc. PT at 60.00
news
a minute ago at talkmarkets.com         
3 Highly Ranked Medical Stocks To Buy Amid Recent Market Volatility JAZZ, OPCH, PCRX
news
2 days ago at finance.yahoo.com         
Why Jazz Pharmaceuticals is a Top Momentum Stock for the Long-Term
Yahoo News
few days ago at finance.yahoo.com         
Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chi...
Yahoo News
six days ago at thelincolnianonline.com         
3,051 Shares in Jazz Pharmaceuticals plc Purchased by Chesapeake Capital Corp IL
news
over a week ago at finance.yahoo.com         
SAPA-GP Hosted the 2025 Annual Conference Showcasing Evolving Landscape of Biopharma
Yahoo News
over a week ago at www.macroaxis.com         
Disposition of 1484 shares by Okeefe Kenneth W of Jazz Pharmaceuticals at 111.35 subject to Rule 16b...
Macroaxis News
over a week ago at zacks.com         
Heres Why Jazz Pharmaceuticals is a Strong Value Stock
zacks News
over a week ago at zacks.com         
Follow the Leader 2 Biopharma Stocks Showing Relative Strength in 2025
zacks News
over a week ago at zacks.com         
Bull of the Day Jazz Pharmaceuticals
zacks News
over two weeks ago at zacks.com         
Finding Great Momentum Stocks to Buy in March During the Selloff
zacks News
2 days ago at gurufocus.com         
Deep Track Capital, LP Acquires Significant Stake in Dianthus Therapeutics Inc
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Suvretta Capital Management, LLC Acquires Significant Stake in Aadi Bioscience Inc
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
AlphaQuest LLC Has 333,000 Stake in Intra-Cellular Therapies, Inc.
news
over two weeks ago at kalkinemedia.com         
Is Intra-Cellular Therapies Enhancing Its Market Position Amid Strong Institutional Backing?
news
over two weeks ago at zacks.com         
JNJ Halts Development of Depression Drug Over Efficacy Concerns
zacks News
over two weeks ago at www.macroaxis.com         
Disposition of 13133 shares by Halstead Michael of Intracellular subject to Rule 16b-3
Macroaxis News
over three weeks ago at thelincolnianonline.com         
IFP Advisors Inc Buys 2,348 Shares of Intra-Cellular Therapies, Inc.
news
over three weeks ago at insidermonkey.com         
Intra-Cellular Therapies, Inc. Among the Best Psychedelic Stocks to Buy in 2025
insidermonkey News
over three weeks ago at thelincolnianonline.com         
Phocas Financial Corp. Sells 16,348 Shares of Intra-Cellular Therapies, Inc.
news
over three weeks ago at businesswire.com         
ITCI Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc...
businesswire News
a day ago at finance.yahoo.com         
Is Iovance Biotherapeutics, Inc. The Top Penny Stock That Will Skyrocket?
Yahoo News
few days ago at gurufocus.com         
Iovance Biotherapeutics Inc Announces Inducement Stock Options for New Employees
Gurufocus Stories at Macroaxis
few days ago at globenewswire.com         
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635
Macroaxis News: globenewswire.com
six days ago at thelincolnianonline.com         
11,400 Shares in Iovance Biotherapeutics, Inc. Purchased by Kazazian Asset Management LLC
news
over a week ago at insidermonkey.com         
Is Iovance Biotherapeutics, Inc. the Most Oversold Penny Stocks to Buy According to Analysts?
insidermonkey News
over a week ago at fool.com         
Down Nearly 80 percent From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up?
fool News
over two weeks ago at www.macroaxis.com         
Acquisition by Bellemin Jean-marc of 93750 shares of Iovance Biotherapeutics subject to Rule 16b-3
Macroaxis News
over three weeks ago at simplywall.st         
Iovance Biotherapeutics, Inc. Just Reported Earnings, And Analysts Cut Their Target Price
Simply Wall St News at Macroaxis
over three weeks ago at finance.yahoo.com         
Iovance Biotherapeutics Full Year 2024 Earnings EPS Misses Expectations
Yahoo News
over three weeks ago at finance.yahoo.com         
Acquisition by Vogt Frederick G of 41662 shares of Iovance Biotherapeutics subject to Rule 16b-3
Yahoo News
over a year ago at news.google.com         
Form 485BPOS INSTITUTIONAL FIDUCIARY - StreetInsider.com
Google News at Macroaxis
a day ago at gurufocus.com         
Illumina Inc Announces Board Leadership Changes
Gurufocus Stories at Macroaxis
few days ago at benzinga.com         
Cathie Woods Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And A...
benzinga news
few days ago at finance.yahoo.com         
Weekly Recap 14 Health Press Releases You Need to See
Yahoo News
few days ago at finance.yahoo.com         
China to Welcome Trump-Aligned Senator With Trade Talks Stalled
Yahoo News
six days ago at watcher.guru         
Chinas 21B Tariff Strike US Agriculture in the Crosshairs
news
over a week ago at finance.yahoo.com         
Illumina, Inc. Among the Best Biotech Stocks to Buy According to Billionaires
Yahoo News
over a week ago at zacks.com         
Why Illumina is a Top Value Stock for the Long-Term
zacks News
over a week ago at insidermonkey.com         
Jim Cramer on Illumina A Challenged Company That He Doesnt Prefer
insidermonkey News
over a week ago at thelincolnianonline.com         
Swiss National Bank Has 59.97 Million Position in Illumina, Inc.
news
over a week ago at finance.yahoo.com         
Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to De...
Yahoo News
over a year ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over a year ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over a year ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over a year ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over a year ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over a year ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over a year ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over a year ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
a minute ago at thelincolnianonline.com         
Mascoma Wealth Management LLC Buys 1 Shares of Gilead Sciences, Inc.
news
2 days ago at finance.yahoo.com         
EMA Accepts GSKs Filing for Expanded Use of Nucala in COPD
Yahoo News
3 days ago at thelincolnianonline.com         
Crowley Wealth Management Inc. Purchases Shares of 2,480 Gilead Sciences, Inc.
news
few days ago at gurufocus.com         
Gilead Sciences Inc Shares Up 1.14 percent on Mar 22
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
OPTN Stock Soars 53 percent on Inking 330M Deal to be Acquired by Paratek
Yahoo News
few days ago at finance.yahoo.com         
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
Yahoo News
few days ago at investors.com         
ARS Pharma Retakes Its 50-Day Line In Bullish Post-Earnings Move. Heres Why.
Investors Business Daily at Macroaxis
six days ago at smh.com.au         
The Handmaids Tale is back for its final season. Heres what we know.
news
over a week ago at seekingalpha.com         
Gilead, GSK could be impacted by potential HHS HIV prevention cuts
seekingalpha News
over a week ago at thelincolnianonline.com         
Disposition of 2500 shares by Andrew Dickinson of Gilead Sciences at 110.53 subject to Rule 16b-3
news
over six months ago at seekingalpha.com         
Ono Pharmaceutical completes tender offer for Deciphera
seekingalpha News
over six months ago at finance.yahoo.com         
Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study o...
Yahoo News
over six months ago at news.google.com         
Charles Schwab Investment Management Inc. Has 8.31 Million Position in Deciphera Pharmaceuticals, In...
Google News at Macroaxis
over six months ago at news.google.com         
Decipheras Shares Surge 74.3 percent in a Month Heres Why - Zacks Investment Research
Google News at Macroaxis
over six months ago at zacks.com         
Heres What Key Metrics Tell Us About Deciphera Pharmaceuticals Q1 Earnings
zacks News
over six months ago at news.google.com         
Deciphera Pharmaceuticals Investment Analysts Weekly Ratings Changes - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Biotech Stock Roundup GILDs GSK Q1 Earnings, DCPH Soars on Acquisition News More
Yahoo News
over six months ago at benzinga.com         
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates HRT, DCPH, UMBF
benzinga news
over six months ago at seekingalpha.com         
ONO to acquire Deciphera Pharmaceuticals in 2.4B deal
seekingalpha News
over six months ago at businesswire.com         
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For 2.4 Billion
businesswire News
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
2 days ago at seekingalpha.com         
Biogen plans new headquarters at Kendall Common
seekingalpha News
few days ago at simplywall.st         
Are Biogen Inc.s Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Simply Wall St News at Macroaxis
few days ago at finance.yahoo.com         
CTI Acquires MP Productions of Little Rock, AR
Yahoo News
six days ago at thelincolnianonline.com         
Evoke Wealth LLC Purchases 112 Shares of Biogen Inc.
news
six days ago at finance.yahoo.com         
Biogen Inc. Among the Most Undervalued Biotech Stocks to Invest In
Yahoo News
over a week ago at finance.yahoo.com         
Stoke CEO exits Medicare drug price talks advance
Yahoo News
over a week ago at businesswire.com         
Stoke Therapeutics Announces CEO Transition
businesswire News
over a week ago at businesswire.com         
SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General Kahn Swick Foti, LLC ...
businesswire News
over a week ago at finance.yahoo.com         
Can BIIBs New Drugs Revive Growth as Multiple Sclerosis Sales Fall?
Yahoo News
a day ago at benzinga.com         
Heres How Much 100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
benzinga news
over a week ago at thelincolnianonline.com         
Ascendis Pharma AS Price Target Raised to 200.00
news
over a week ago at simplywall.st         
Optimistic Investors Push Ascendis Pharma AS Shares Up 26 percent But Growth Is Lacking
Simply Wall St News at Macroaxis
over two weeks ago at news.google.com         
How the price action is used to our Advantage - Stock Traders Daily
Google News at Macroaxis
over three weeks ago at finance.yahoo.com         
OMass Therapeutics appoints Birgitte Volck as Non-Executive Director
Yahoo News
over three weeks ago at finance.yahoo.com         
Ascendis Pharma to Participate in theTD Cowen 45th Annual Health Care Conference
Yahoo News
over a month ago at finance.yahoo.com         
FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA
Yahoo News
over a month ago at thelincolnianonline.com         
Rice Hall James Associates LLC Has 22.56 Million Stock Holdings in Ascendis Pharma AS
news
over a month ago at gurufocus.com         
RA CAPITAL MANAGEMENT, L.P. Reduces Stake in Recursion Pharmaceuticals Inc
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
Ascendis Pharma AS Q4 2024 Earnings Call Highlights Strategic Growth and Market ...
Yahoo News
3 days ago at thelincolnianonline.com         
Simplify Asset Management Inc. Reduces Stake in argenx SE
news
over a week ago at thelincolnianonline.com         
argenx Upgraded to Outperform at Sanford C. Bernstein
news
over a week ago at zacks.com         
EXEL vs. ARGX Which Stock Should Value Investors Buy Now?
zacks News
over two weeks ago at gurufocus.com         
argenx SE Announces Promising Data for VYVGART at AAN Annual Meeting
Gurufocus Stories at Macroaxis
over two weeks ago at kalkinemedia.com         
Is argenx SE Expanding Its Role in the Biotechnology Sector?
news
over three weeks ago at thelincolnianonline.com         
Dynasty Wealth Management LLC Acquires 22 Shares of argenx SE
news
over three weeks ago at zacks.com         
Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus
zacks News
over three weeks ago at zacks.com         
CORTs Q4 Earnings and Revenues Fall Short of Estimates
zacks News
over three weeks ago at gurufocus.com         
argenx to Present at TD Cowen 45th Annual Healthcare Conference
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
argenx SE Announces Upcoming Conference Call for 2024 Financial Results
Gurufocus Stories at Macroaxis
a minute ago at businesswire.com         
AstraZenecas Full Year and Q4 2024 results
businesswire News
2 days ago at zacks.com         
Amgen Stock Drops Despite Market Gains Important Facts to Note
zacks News
3 days ago at insidermonkey.com         
Is Amgen Inc. The Best Healthcare Dividend Stock to Invest in?
insidermonkey News
few days ago at thelincolnianonline.com         
Promising Healthcare Stocks To Follow Now March 22nd
news
few days ago at zacks.com         
Why Amgen is a Top Value Stock for the Long-Term
zacks News
few days ago at thelincolnianonline.com         
Disposition of 3150 shares by Jonathan Graham of Amgen at 313.71 subject to Rule 16b-3
news
few days ago at thelincolnianonline.com         
Fiduciary Group LLC Trims Stock Holdings in Amgen Inc.
news
few days ago at finance.yahoo.com         
BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Q...
Yahoo News
six days ago at thelincolnianonline.com         
Generali Investments Management Co LLC Makes New 1.67 Million Investment in Amgen Inc.
news
six days ago at finance.yahoo.com         
Disposition of 3305 shares by Peter Griffith of Amgen at 313.71 subject to Rule 16b-3
Yahoo News
2 days ago at finance.yahoo.com         
Q4 Rundown Moderna Vs Other Therapeutics Stocks
Yahoo News
few days ago at zacks.com         
Heres Why BioMarin Pharmaceutical is a Strong Value Stock
zacks News
few days ago at zacks.com         
BioMarin Up 4.2 percent Since Last Earnings Report Can It Continue?
zacks News
few days ago at finance.yahoo.com         
BioMarin Pharmaceutical Among Paul Singers Latest Portfolios Top Stock Picks
Yahoo News
over a week ago at finance.yahoo.com         
Is BioMarin Pharmaceutical the Best Biotech Stock According to Billionaires?
Yahoo News
over a week ago at finance.yahoo.com         
BMRN vs. CSLLY Which Stock Should Value Investors Buy Now?
Yahoo News
over a week ago at finance.yahoo.com         
Heres Why BioMarin Pharmaceutical is a Strong Growth Stock
Yahoo News
over a week ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over a week ago at zacks.com         
AMRNs Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan
zacks News
over a week ago at finance.yahoo.com         
Why BioMarin Pharmaceutical is a Top Momentum Stock for the Long-Term
Yahoo News
a minute ago at finance.yahoo.com         
Neurocrines Phase II schizophrenia trial fails to meet primary endpoint
Yahoo News
few days ago at gurufocus.com         
Neurocrine Biosciences Inc Unveils Promising INGREZZA Data for Huntingtons Disease Chorea
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
Neurocrine Biosciences Presents 48-Week Remission Data on Treatment of Tardive Dyskinesia With INGRE...
Yahoo News
over a week ago at finance.yahoo.com         
Neurocrine Biosciences Presents New KINECT-HD Data Showing Significant Reduction in Chorea Across Bo...
Yahoo News
over a week ago at www.macroaxis.com         
Acquisition by Roberts Eiry of 1860 shares of Neurocrine Biosciences subject to Rule 16b-3
Macroaxis News
over two weeks ago at thelincolnianonline.com         
Edgestream Partners L.P. Grows Stock Position in Neurocrine Biosciences, Inc.
news
over two weeks ago at thelincolnianonline.com         
Andra AP fonden Sells 77,600 Shares of Neurocrine Biosciences, Inc.
news
over two weeks ago at finance.yahoo.com         
Neurocrine Biosciences initiates trial of VMAT2 inhibitor in healthy adults
Yahoo News
over two weeks ago at finance.yahoo.com         
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBI-1140675, a Seco...
Yahoo News
over three weeks ago at benzinga.com         
Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study...
benzinga news
over a year ago at news.google.com         
Content is king Digital materials linked to 2.5 times boost to new ... - FiercePharma
Google News at Macroaxis
a minute ago at simplywall.st         
Heron Therapeutics, Inc.s Shares Bounce 48 percent But Its Business Still Trails The Industry
Simply Wall St News at Macroaxis
over a week ago at koreatimes.co.kr         
Army partially suspends drone flights after helicopter collision
news
over two weeks ago at www.macroaxis.com         
Acquisition by Morgan Adam of 17950 shares of Heron Therapeuti subject to Rule 16b-3
Macroaxis News
over three weeks ago at finance.yahoo.com         
Heron Therapeutics, Inc. Just Reported Earnings, And Analysts Cut Their Target Price
Yahoo News
over three weeks ago at finance.yahoo.com         
Heron Therapeutics Inc Q4 2024 Earnings Call Highlights Record Revenue Growth and ...
Yahoo News
over three weeks ago at finance.yahoo.com         
Heron Therapeutics shareholders are up 19 percent this past week, but still in the red over the last...
Yahoo News
over three weeks ago at insidermonkey.com         
Heron Therapeutics, Inc. Q4 2024 Earnings Call Transcript
insidermonkey News
over three weeks ago at finance.yahoo.com         
Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Rece...
Yahoo News
over three weeks ago at gurufocus.com         
Heron Therapeutics Inc Q4 2024 Earnings EPS of 0. ...
Gurufocus Stories at Macroaxis
over three weeks ago at finance.yahoo.com         
Disposition of 756 shares by Lisa Peraza of Heron Therapeuti at 2.15 subject to Rule 16b-3
Yahoo News
Far too much social signal, news, headlines, and media speculation about Franklin Biotechnology that are available to investors today. That information is available publicly through Franklin media outlets and privately through word of mouth or via Franklin internal channels. However, regardless of the origin, that massive amount of Franklin data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Franklin Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Franklin Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Franklin Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Franklin Biotechnology alpha.

Other Information on Investing in Franklin Mutual Fund

Franklin Biotechnology financial ratios help investors to determine whether Franklin Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Franklin with respect to the benefits of owning Franklin Biotechnology security.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments